Intra-Cellular Therapies Inc header image

Intra-Cellular Therapies Inc

ITCI

Equity

ISIN null / Valor 23194616

NASDAQ (2025-04-03)

USD 131.87%

Intra-Cellular Therapies Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Intra-Cellular Therapies Inc is a biopharmaceutical company that focuses on developing therapies based on Dr. Paul Greengard's Nobel Prize-winning research on the inner workings of cells in the body. The company is led by experienced industry professionals and scientific advisors, aiming to bring innovative treatments to market for various medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

95.9%1Y

110%3Y

816%5Y

Performance

6.70%1Y

42.5%3Y

46.8%5Y

Volatility

8996 M

Market cap (USD)

Daily traded volume (Shares)

84.6 / 82.43

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Conmed Corp

Conmed Corp Valor: 920278

Annual Return

-50%0%+50%

Risk level

110

0.25%USD 36.80

National Healthcare Corp

National Healthcare Corp Valor: 836282

Annual Return

-50%0%+50%

Risk level

110

0.01%USD 157.73

Dexcom Inc

Dexcom Inc Valor: 2107726

Annual Return

-50%0%+50%

Risk level

110

-0.58%USD 67.27

Insulet Corp

Insulet Corp Valor: 2941247

Annual Return

-50%0%+50%

Risk level

110

-0.72%USD 228.63

Henry Schein Inc

Henry Schein Inc Valor: 83527

Annual Return

-50%0%+50%

Risk level

110

-0.60%USD 72.68

NovoCure Limited

NovoCure Limited Valor: 29570025

Annual Return

-50%0%+50%

Risk level

110

0.75%USD 12.15

Roivant Sciences Limited

Roivant Sciences Limited Valor: 113331044

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 27.80

Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp Valor: 912247

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 8.90

ICU Medical Inc

ICU Medical Inc Valor: 940704

Annual Return

-50%0%+50%

Risk level

110

1.07%USD 126.63

CRISPR Therapeutics Ltd

CRISPR Therapeutics Ltd Valor: 33408113

Annual Return

-50%0%+50%

Risk level

110

-1.55%USD 46.95

SIX

FactSet

Clearbit

Logos provided by Clearbit